Wolverine Trading
ONCE

Wolverine Trading’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Wolverine Trading’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-3,999
Closed -$455K – 5485
2019
Q1 		$455K Sell
3,999
-10,937
-73% -$804K ﹤0.01% 2887
2018
Q4 		$576K Buy
14,936
+4,824
+48% +$209K ﹤0.01% 2502
2018
Q3 		$552K Buy
+10,112
New +$691K ﹤0.01% 3003
2018
Q1 		– Sell
-11,835
Closed -$683K – 6186
2017
Q4 		$609K Buy
+11,835
New +$850K ﹤0.01% 2769

Other funds holding ONCE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Wolverine Trading's ONCE Position: Q2 2019 in Review

Wolverine Trading sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q2 2019, closing a stake of 3,999 shares — an estimated $455K sold.

Wolverine Trading first reported a position in ONCE in Q4 2017 and held it in 4 quarters. The position peaked at $609K in Q4 2017. 194 funds tracked by Wall St. Rank hold ONCE as of Q2 2019.

  • Wolverine Trading reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Wolverine Trading sold 3,999 Spark Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $455K.
  • Wolverine Trading first reported a position in Spark Therapeutics, Inc. Common Stock in Q4 2017 and held it in 4 quarters.
  • Wolverine Trading's Spark Therapeutics, Inc. Common Stock position peaked at $609K in Q4 2017.
  • 194 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Wolverine Trading's 13F filing for Q2 2019, filed 20 Aug 2019.